Outcomes with perioperative durvalumab (D) in pts with resectable NSCLC and baseline N2 lymph node involvement (N2 R-NSCLC): An exploratory subgroup analysis of AEGEAN Meeting Abstract
| Authors: | Heymach, J.; Reck, M.; Mitsudomi, T.; Taube, J. M.; Spira, A. I.; Chaft, J. E.; Doherty, G. J.; Mann, H.; Fouad, T. M.; Harpole, D. H. |
| Abstract Title: | Outcomes with perioperative durvalumab (D) in pts with resectable NSCLC and baseline N2 lymph node involvement (N2 R-NSCLC): An exploratory subgroup analysis of AEGEAN |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401804 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.8011 |
| Notes: | Meeting Abstract: 8011 -- Source: Wos |
